12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe

Clinical trial NCT00525824 · COMPLETED

Trial details

NCT number: NCT00525824
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia Coronary Heart Disease Atherosclerosis

Start date: 2007-08-01
Primary completion: 2008-09-01
Enrollment: 1743

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.